Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mewes JC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-8 z 8
    Tytuł:
    Early modelling of the effects and healthcare costs of the Dutch citizen-rescuer system for out-of-hospital cardiac arrests.
    Autorzy:
    Ahmed A; Panaxea B.V., Den Bosch, The Netherlands.
    Mewes JC; Panaxea B.V., Den Bosch, The Netherlands.
    Lepage-Nefkens I; Panaxea B.V., Den Bosch, The Netherlands.
    Tan HL; Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, The Netherlands.; Netherlands Heart Institute, Utrecht, The Netherlands.
    Vrijhoef HJM; Panaxea B.V., Den Bosch, The Netherlands.
    Pokaż więcej
    Corporate Authors:
    ESCAPE-NET Investigators
    Źródło:
    PloS one [PLoS One] 2023 Nov 10; Vol. 18 (11), pp. e0293965. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Out-of-Hospital Cardiac Arrest*/epidemiology
    Out-of-Hospital Cardiac Arrest*/therapy
    Adult ; Humans ; Health Care Costs ; Netherlands/epidemiology ; Cost-Benefit Analysis ; Quality-Adjusted Life Years
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland.
    Autorzy:
    Mewes JC; Panaxea b.v., Amsterdam, North Holland, The Netherlands.
    Lindenberg M; Panaxea b.v., Amsterdam, North Holland, The Netherlands.
    Vrijhoef HJM; Panaxea b.v., Amsterdam, North Holland, The Netherlands.; Maastricht University Medical Center, Limburg, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Jun 28; Vol. 17 (6), pp. e0270490. Date of Electronic Publication: 2022 Jun 28 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Pre-Eclampsia*/prevention & control
    Cost-Benefit Analysis ; Female ; Germany/epidemiology ; Humans ; Infant, Newborn ; Pregnancy ; Pregnancy Trimester, First ; Switzerland/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Autorzy:
    Mewes JC; Panaxea B.V., Amsterdam, the Netherlands.
    Pulia MS; BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America.
    Mansour MK; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.
    Broyles MR; Department of Clinical Pharmacy and Laboratory Services, Five Rivers Medical Center, Pocahontas, AR, United States of America.
    Nguyen HB; Division of Pulmonary, Critical Care, Hyperbaric and Sleep Medicine, Loma Linda University, Loma Linda, CA, United States of America.; Department of Emergency Medicine, Loma Linda University, Loma Linda, CA, United States of America.
    Steuten LM; Panaxea B.V., Amsterdam, the Netherlands.; Fred Hutchinson Cancer Research Center, Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, United States of America.; University of Washington, School of Pharmacy, the CHOICE Institute, Seattle, WA, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Apr 23; Vol. 14 (4), pp. e0214222. Date of Electronic Publication: 2019 Apr 23 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Costs and Cost Analysis*
    Economics, Medical*
    Models, Economic*
    Antimicrobial Stewardship/*economics
    Calcitonin/*metabolism
    Hospitalization/*economics
    Respiratory Tract Infections/*drug therapy
    Sepsis/*drug therapy
    Humans ; Respiratory Tract Infections/economics ; Sepsis/economics ; Treatment Outcome ; United States
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.
    Autorzy:
    Retèl VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands. .; Department of Health Technology and Services Research, University of Twente, Postbus 217, 7500, AE, Enschede, the Netherlands. .
    Steuten LMG; Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, P.O. Box 19024, Seattle, WA, 98109-1024, USA.
    Geukes Foppen MH; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.
    Mewes JC; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.
    Lindenberg MA; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Postbus 217, 7500, AE, Enschede, the Netherlands.
    Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.
    van Harten WH; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Postbus 217, 7500, AE, Enschede, the Netherlands.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2018 Sep 15; Vol. 18 (1), pp. 895. Date of Electronic Publication: 2018 Sep 15.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cost-Benefit Analysis*
    Immunotherapy/*economics
    Lymphocytes, Tumor-Infiltrating/*immunology
    Melanoma/*drug therapy
    Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/economics ; Denmark/epidemiology ; Disease-Free Survival ; Female ; Humans ; Ipilimumab/administration & dosage ; Ipilimumab/economics ; Lymphocytes, Tumor-Infiltrating/transplantation ; Male ; Melanoma/economics ; Melanoma/pathology ; Models, Economic ; Netherlands/epidemiology ; Quality-Adjusted Life Years
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries.
    Autorzy:
    Mewes JC; Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. j.c.mewes@utwente.nl.
    Steuten LM; Hutchinson Institute for Cancer Outcomes Research, University of Washington, 1110 Fairview Avenue North, 98109 WA, Seattle, USA. .
    Groeneveld IF; Rijnlands Rehabilitation Centre, Wassenaarseweg 501, 2333 AL, Leiden, The Netherlands. .; Sophia Rehabilitation, Vrederustlaan 180, 2543 SW, The Hague, The Netherlands. .
    de Boer AG; Coronel Institute of Occupational Health, Amsterdam Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .
    Frings-Dresen MH; Coronel Institute of Occupational Health, Amsterdam Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .
    IJzerman MJ; Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. .
    van Harten WH; Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. .; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2015 Nov 12; Vol. 15, pp. 899. Date of Electronic Publication: 2015 Nov 12.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Health Care Costs*
    Neoplasms/*economics
    Rehabilitation, Vocational/*economics
    Return to Work/*economics
    Adult ; Cost-Benefit Analysis ; Counseling/economics ; Efficiency ; Europe ; Exercise Therapy/economics ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/rehabilitation ; Netherlands ; Sick Leave ; Survivors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-8 z 8

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies